A form of immunotherapy that harnesses the power of CD4 T-cells was shown to be safe and effective in patients with various types of metastatic cancers.
Sandra Hanner
Advertisement
Articles by Sandra Hanner
Advertisement
Latest Updated Articles
MAGE-A3—Targeted Adoptive T-Cell Therapy Shows Promise in Solid TumorsPublished: April 17th 2016 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
4
Quarter Century Update: Future Predictions for the Field
5
